How Stem Cell Therapy Works: The Inflammation Reset Explained

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX

A patient sat across from me a few weeks ago, rubbing a left knee that had been angry for two years. "So the stem cells," she said, "they turn into new cartilage, right?" It's the picture most people carry around. Cells go in, fresh tissue grows, pain disappears. I wish it were that tidy.

The reality is more interesting, and honestly more useful to understand before you spend a dime. As an internal medicine physician and the Medical Director at Magnolia Functional Wellness here in Southlake, I spend a lot of my consult time undoing that cartoon version. What the research increasingly points to isn't a story about cells becoming tissue. It's a story about cells changing the conversation inside an inflamed joint or organ. That's what I mean by an inflammation reset.

Why inflammation is the real problem in so many "wear and tear" conditions

Take that knee. Cartilage has almost no blood supply, so it repairs itself poorly. Once the joint environment tips toward chronic, low-grade inflammation, a loop starts. Inflammatory signals break down matrix. Breakdown products irritate the lining of the joint. The lining makes more inflammatory signals. Around and around it goes, and meanwhile you stop walking the dog because stairs hurt.

You'll see versions of the same loop in tendons, in the low back, and in a handful of autoimmune conditions. The tissue isn't just damaged. The local environment has stopped favoring repair. In functional medicine training, we're taught to ask what's driving a problem rather than only what's broken, and in many musculoskeletal complaints the answer is a stubborn inflammatory microenvironment that ordinary rest and anti-inflammatory pills don't change.

Can you quiet that environment without suppressing the whole immune system? That's the question regenerative medicine is trying to answer, and it's where the cell-based approaches get their rationale.

What mesenchymal stem cells actually do

The cells most often discussed in this setting are called mesenchymal stem cells, or MSCs (the field also uses the terms mesenchymal stromal cells and multipotential stromal cells, which tells you how much the naming has been argued over). They can be found in bone marrow, fat tissue, and umbilical cord tissue.

Here's the part that surprised me when I first dug into the literature. In a lab dish, MSCs can be coaxed into becoming bone, cartilage, or fat cells. But inside the body, after implantation, that kind of transformation happens only in limited situations. A widely cited 2019 review by Pittenger, Discher, Péault and colleagues in npj Regenerative Medicine states it plainly: MSCs can differentiate under defined conditions in vitro and in limited situations after implantation in vivo, and their broad anti-inflammatory and immune-modulatory properties are the greatest focus of human clinical testing. The same review notes the work has grown into more than 950 clinical trials.

Read that again. The headline property isn't "builds new tissue." It's "modulates inflammation and immune activity."

The working theory is that MSCs act like a coordinator more than a bricklayer. They respond to the signals around them, and in turn they release their own: growth factors, cytokines that dial down inflammatory activity, and tiny packets of cellular messages called extracellular vesicles. Immune cells nearby get nudged from an aggressive, tissue-damaging posture toward a calmer, repair-friendly one. That's the reset. Not a wipe, a recalibration.

What a reset looks like in practice, and what it doesn't

I want to be careful here, because this is exactly where the marketing in our industry gets sloppy.

When it works, patients don't wake up one morning with a new knee. What they describe is subtler. Morning stiffness eases. A joint that flared after every Saturday at Bob Jones Park starts tolerating more. The pain doesn't vanish, it recedes enough to let them rebuild strength, and strength is what protects a joint long term. In my practice, I tell people the cells open a window. Rehab, body weight, sleep, blood sugar, and hormone status determine whether you use it.

Timing matters too. This isn't a switch. Most people notice little in the first few weeks, early changes tend to appear around months two and three, and the fuller picture often takes four to six months as tissue remodels. That's why we schedule a six-month check-in at Magnolia rather than promising anything at the two-week mark.

And it doesn't work for everyone. I'll say that out loud in consults because it's true. Response varies with the condition, how advanced the damage is, the source and quality of the cell preparation, and the person. A fully collapsed joint space or a nerve that's actively compressed isn't an inflammation problem, and no cell product will fix a structural problem that needs a surgeon.

The honest regulatory picture

You should know the rules of the road. The only stem cell products the FDA has approved in the United States are blood-forming cells derived from cord blood, used for specific blood and immune disorders. The MSC and related products discussed in regenerative wellness settings are not FDA-approved treatments for orthopedic, anti-aging, or autoimmune uses. Research is active, and trials are ongoing, but that's the current status.

Why does that matter for you as a patient? Because it means the quality of what you're given, and the honesty of the person giving it, carries more weight than usual. A few questions worth asking any clinic:

• Where does the cell or biologic product come from, and what lab processes it?
• What documentation exists on viability and handling?
• Will you tell me plainly that this isn't an FDA-approved treatment for my condition?
• What evidence supports using it for my specific problem, and what don't we know?

If the answers get vague or the promises get big, walk out. I'd rather lose a sale than have someone leave with a false impression.

Where cells fit alongside PRP and everything else

Stem cell approaches are one tool among several in what's often called orthobiologics, which is the umbrella for treatments built from biologic material. Platelet-rich plasma, made from your own blood, delivers concentrated growth factors and is often the first thing I consider for a tendon or a mildly arthritic joint. Cell-based options come into the conversation when the problem is more entrenched or when inflammation looks like the main driver. Sometimes we use them in combination, and sometimes the right answer is neither.

You can read how we approach this on our orthobiologics page, and we cover the PRP side of the equation on our PRP injections page.

One more thing that rarely makes it into the brochures. The inflammatory environment you're trying to calm doesn't exist in isolation. Uncontrolled blood sugar, poor sleep, low testosterone or estrogen, and excess visceral fat all feed the same inflammatory loop. If you inject cells into a body that keeps stoking the fire, you shouldn't be surprised when the benefit fades. That's the functional medicine piece: fix the soil while you plant.

Source, processing, and safety: the unglamorous details

Bone marrow, fat tissue, and umbilical cord tissue all get used, and none is automatically better. Marrow and fat come from you, which means a collection procedure and a bit of recovery. Cord-derived products skip that step but raise different questions about processing, handling, and documentation. Each source has tradeoffs in potency, preparation, and cost, and I'd be suspicious of anyone who claims one is simply superior across the board.

What about safety? Across the published trials, cell-based treatments have generally been tolerated reasonably well, with the most common issues being temporary soreness, swelling, or a flare at the injection site, plus the usual small risks of any needle procedure such as bleeding or infection. But "reasonably safe in studies" isn't the same as "proven to work," and that gap is where a lot of clinics quietly blur things. Safety data answers one question. Efficacy data answers another. You deserve both answers, and for many conditions the efficacy answer is still "we're not sure yet."

That uncertainty is why I'm comfortable offering cell-based options only for problems where the biology makes sense and the early evidence is encouraging, and why I decline to offer them where it isn't. I'd rather tell you no than sell you hope.

What to do before you ever book a procedure

Get the diagnosis right first. Honestly, this step gets skipped more than it should. Knee pain can come from the meniscus, the cartilage, a ligament, referred pain from the hip or back, or a metabolic problem. Each calls for something different. Imaging, a hands-on exam, and basic labs (inflammatory markers, glucose, thyroid, vitamin D, and hormone levels when they're relevant) tell me whether an inflammation reset is even the right target.

Then ask what you'll do differently afterward. If the plan is simply to receive an injection and go back to the same habits, I'd expect a short-lived benefit at best. If the plan includes a strength program, better sleep, steadier blood sugar, and addressing whatever hormonal or metabolic drivers we find, you're stacking the odds in your favor. Our Texas summers don't help, by the way. When it's 100 degrees out, people stop moving outdoors, and a stiff joint gets stiffer. Build indoor movement into the plan from day one.

Who I think should consider this, and who shouldn't

A good candidate is typically someone with a defined musculoskeletal problem, imaging that shows the structure is still worth saving, and a willingness to do the unglamorous work around it. Someone who has tried conservative care first. Someone who understands that "reasonable chance of meaningful improvement" is the honest ceiling of what I can promise.

Someone who's hoping for a cure for a systemic disease, who's skipping their prescribed medications, or who wants a shortcut around physical therapy isn't there yet, and I'll say so. Active cancer, active infection, and certain bleeding or immune conditions can rule treatment out entirely, which is why I look at your full history and imaging before anyone gets scheduled.

So back to my patient with the knee. I told her what I'm telling you. The cells probably won't become her new cartilage. What they might do is quiet a joint that's been stuck in an inflammatory loop long enough for her to get stronger and move again. That's a smaller claim than the brochure version, and it's the one I can stand behind.

If you're in Southlake or elsewhere in North Texas and wondering whether a regenerative approach makes sense for your situation, the first step at Magnolia Functional Wellness is a conversation, a look at your imaging and labs, and a straight answer about whether it's worth your time and money.